Is it safe for a patient with polyarthritis inflammatory on Leflunomide (20 mg daily) to receive the MMR (Measles, Mumps, Rubella) vaccine and the inactivated flu shot?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vaccination Safety in Polyarthritis Inflammatory Patients on Leflunomide

The inactivated flu shot is safe and should be administered without delay, but the MMR vaccine is contraindicated while on leflunomide 20 mg daily due to its immunosuppressive effects. 1

Inactivated Influenza Vaccine (Safe - Administer)

The flu shot should be given regardless of leflunomide therapy, as inactivated vaccines are safe in patients on immunosuppressive DMARDs. 1

  • Non-live vaccines can be administered to patients with autoimmune inflammatory rheumatic diseases during use of disease-modifying antirheumatic drugs (DMARDs) like leflunomide 1
  • Inactivated influenza vaccine should not be withheld because of concerns about exacerbation of chronic immune-mediated or inflammatory illness 1
  • Studies demonstrate adequate immune response to influenza vaccine in patients with rheumatic diseases receiving disease-modifying drugs, though immunogenicity may be somewhat reduced 1
  • Leflunomide acts as an immunomodulator by inhibiting lymphocyte proliferation, placing patients in a category requiring immunosuppression considerations 2

Practical Considerations for Flu Vaccine

  • Use only the inactivated (killed) influenza vaccine, never the live-attenuated nasal spray (LAIV) 1
  • The vaccine can be administered without interrupting leflunomide therapy 1
  • Vaccination does not increase disease activity in patients with inflammatory arthritis 1

MMR Vaccine (Contraindicated - Do Not Administer)

MMR vaccine should not be administered while on leflunomide 20 mg daily, as live-attenuated vaccines are contraindicated in patients on maintenance immunosuppression. 1

  • Live-attenuated vaccines should not be administered to patients with chronic inflammatory diseases on maintenance immunosuppression, including MMR vaccine in patients receiving both low-level and high-level immunosuppression 1
  • The American College of Rheumatology conditionally recommends deferring live-attenuated vaccines for patients with rheumatic diseases on immunosuppressive therapy due to risk of uncontrolled viral replication 3
  • Leflunomide is classified as an immunosuppressive DMARD that increases risk of immunosuppression according to product labeling 2

Evidence on MMR in Similar Populations

  • The available safety data for MMR vaccination in rheumatic disease patients comes primarily from booster (revaccination) studies in pediatric populations on low-dose methotrexate or etanercept, not primary vaccination in adults on leflunomide 1
  • One small study showed 11 of 12 rheumatoid arthritis patients (including 10 on leflunomide) who inadvertently received yellow fever vaccine (another live vaccine) seroconverted without clinical infection, but this involved a fractionated dose and vaccination should still be avoided per guidelines 4

If MMR is Absolutely Necessary

  • The preferable approach is to administer MMR vaccine 4 weeks before initiating leflunomide therapy 1
  • If already on leflunomide, consider holding the medication for an appropriate period before vaccination and waiting 4 weeks after vaccination before restarting, though this requires careful assessment of disease activity risk 3
  • Due to leflunomide's long half-life (approximately 2 weeks for the active metabolite), a washout procedure with cholestyramine may be necessary to accelerate drug elimination before live vaccination can be considered 2

Common Pitfalls to Avoid

  • Do not confuse inactivated and live vaccines - the flu shot (inactivated) is safe, while MMR (live) is not 1
  • Do not defer the flu vaccine while waiting for immunosuppression to decrease - it should be given on schedule 1
  • Do not assume all vaccines carry the same risk - inactivated vaccines have an excellent safety profile in immunosuppressed patients, while live vaccines pose theoretical infection risk 1
  • Do not use live-attenuated influenza vaccine (nasal spray) in any patient on immunosuppressive therapy 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Live Vaccines in SLE/RA Patients on DMARDs

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What vaccinations are recommended at 1 year of age?
What vaccines should be given today to a 3-year-old child due for influenza (flu), Diphtheria, Tetanus, and Pertussis (DTaP), polio, pneumococcal, Haemophilus influenzae type b (Hib), Hepatitis A (Hep A), varicella, and Measles, Mumps, and Rubella (MMR) vaccines?
What is the best recommendation for a 27-year-old primigravid (first pregnancy) woman at 16 weeks gestation, with a blood type of O, Rh negative, and no immunity to Rubella (German measles) and Varicella (chickenpox), presenting with mild anemia (hemoglobin 11.2 g/dL) and normocytic anemia (mean corpuscular volume 84 fL)?
What are the recommendations for administering non-live vaccines to patients taking Simponi (golimumab) and methotrexate?
What are the recommendations for a 12-month well-child check?
Should a patient with thalassemia minor undergo testing for thalassemia gene mutations?
Can Cipro (ciprofloxacin) be prescribed for a patient with sinusitis?
What are the guidelines for using Agomelatine (antidepressant) in adults with a history of depression, anxiety, or other mental health conditions?
What is the possible diagnosis for a patient with a history of gastrointestinal surgery, chemotherapy, and recurrent antibiotic use, presenting with objective distension, eructation, and shortness of breath after taking N-acetylcysteine (acetilcisteina)?
What is the recommended treatment for a patient with Tinea corporis (ringworm of the body) on the leg?
What is apolipoprotein A and its role in cardiovascular health for an adult patient with concerns about their lipid profile and risk factors for cardiovascular disease, such as high blood pressure, diabetes, or a family history of heart disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question